PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-11.07%
Both yoy net incomes decline, with MCHP at -63.10%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
8.21%
Some D&A expansion while MCHP is negative at -0.55%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
36.36%
Some yoy growth while MCHP is negative at -516.96%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-10.34%
Both cut yoy SBC, with MCHP at -4.46%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
738.30%
Slight usage while MCHP is negative at -46.67%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
194.70%
AR growth while MCHP is negative at -17.43%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-21.58%
Both reduce yoy inventory, with MCHP at -115.96%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
569.23%
A yoy AP increase while MCHP is negative at -41.36%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
7.12%
Lower 'other working capital' growth vs. MCHP's 48.98%. David Dodd would see fewer unexpected short-term demands on cash.
103.13%
Lower 'other non-cash' growth vs. MCHP's 8248.84%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
15.36%
Some CFO growth while MCHP is negative at -49.61%. John Neff would note a short-term liquidity lead over the competitor.
9.42%
Some CapEx rise while MCHP is negative at -27.90%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
50.73%
Purchases growth of 50.73% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-100.00%
We reduce yoy sales while MCHP is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
10542.31%
Growth well above MCHP's 118.35%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
226.08%
Investing outflow well above MCHP's 17.40%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
90.85%
Debt repayment similar to MCHP's 89.86%. Walter Schloss sees parallel liability management or similar free cash flow availability.
-25.64%
Negative yoy issuance while MCHP is 42.69%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-68.87%
Both yoy lines negative, with MCHP at -238.05%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.